Paper42525317
Rutin as a multi-target anti-inflammatory phytochemical in arthritic disorders: pharmacological mechanisms and therapeutic potential.
Nazir MM and 1 other. Inflammopharmacology, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Rutin as a multi-target anti-inflammatory phytochemical in arthritic disorders: pharmacological mechanisms and therapeutic potential. Papers, record 42525317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42525317
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rutin as a multi-target anti-inflammatory phytochemical in arthritic disorders: pharmacological mechanisms and therapeutic potential.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rutin | Major topic |
| Anti-Inflammatory Agents | Major topic |
| Phytochemicals | Major topic |
| Arthritis | Major topic |
| Humans | |
| Animals | |
| Arthritis, Rheumatoid | |
| Osteoarthritis | |
| Arthritis, Gouty |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32620467 | Role of Nrf2 in rheumatoid arthritis. | Curr Res Transl Med | 2020 | https://conductscience.org/library/papers/32620467 | PubMed |
| 2 | 34824210 | The JAK/STAT signaling pathway: from bench to clinic. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34824210 | PubMed |
| 3 | 40932869 | Xuetongsu attenuates synovial inflammation in rheumatoid arthritis by inhibiting the IL-23/IL-17/NF-κB inflammatory axis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40932869 | PubMed |
| 4 | 34987201 | Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/34987201 | PubMed |
| 5 | 35588172 | Rutin Inhibits the Progression of Osteoarthritis Through CBS-Mediated RhoA/ROCK Signaling. | DNA Cell Biol | 2022 | https://conductscience.org/library/papers/35588172 | PubMed |
| 6 | 41247262 | Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption. | Bone Joint Res | 2025 | https://conductscience.org/library/papers/41247262 | PubMed |
| 7 | 41132114 | Natural-based antioxidants in cosmeceuticals: Extraction, bioavailability and skin ageing applications. | Int J Cosmet Sci | 2026 | https://conductscience.org/library/papers/41132114 | PubMed |
| 8 | 34046688 | Clinical, radiologic and serologic profile of patients with interstitial pneumonia with autoimmune features: a cross-sectional study. | Rheumatol Int | 2022 | https://conductscience.org/library/papers/34046688 | PubMed |
| 9 | 35055087 | Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35055087 | PubMed |
| 10 | 28467992 | Rutin Attenuates Oxidative Stress and Proinflammatory Cytokine Level in Adjuvant Induced Rheumatoid Arthritis via Inhibition of NF-κB. | Pharmacology | 2017 | https://conductscience.org/library/papers/28467992 | PubMed |
| 11 | 37938494 | JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions. | Mol Biomed | 2023 | https://conductscience.org/library/papers/37938494 | PubMed |
| 12 | 35360183 | Ingredients of a Natural Oral Nutritional Supplement and Their Role in the Treatment of Osteoarthritis. | Clin Med Insights Arthritis Musculoskelet Disord | 2022 | https://conductscience.org/library/papers/35360183 | PubMed |
| 13 | 40529506 | Molecular mechanisms of neuroprotective effect of rutin. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40529506 | PubMed |
| 14 | 25219641 | Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig. | Osteoarthritis Cartilage | 2015 | https://conductscience.org/library/papers/25219641 | PubMed |
| 15 | 41596127 | Emerging Therapeutic Strategies for Nrf2-Associated Skin Disorders: From Photoaging to Autoimmunity. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41596127 | PubMed |
| 16 | 32368038 | Cyclodextrin-Modified CeO2 Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/32368038 | PubMed |
| 17 | 11680812 | Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. | Farmaco | 2001 | https://conductscience.org/library/papers/11680812 | PubMed |
| 18 | 39906613 | Rutin attenuates complete Freund's adjuvant-induced inflammatory pain in rats. | Iran J Basic Med Sci | 2025 | https://conductscience.org/library/papers/39906613 | PubMed |
| 19 | 35254584 | Berberis lycium fruit extract and its phytoconstituents berberine and rutin mitigate collagen-CFA-induced arthritis (CIA) via improving GSK3β/STAT/Akt/MAPKs/NF-κB signaling axis mediated oxi-inflammation and joint articular damage in murine model. | Inflammopharmacology | 2022 | https://conductscience.org/library/papers/35254584 | PubMed |
| 20 | 27539668 | Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. | Nat Rev Rheumatol | 2016 | https://conductscience.org/library/papers/27539668 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| ISYNA1 | 51477 | PubTator's text mining | https://conductscience.org/library/genes/51477 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
| RHOA | 387 | PubTator's text mining | https://conductscience.org/library/genes/387 | NCBI Gene |
| SIRT1 | 23411 | PubTator's text mining | https://conductscience.org/library/genes/23411 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42525317
GET https://conductscience.org/api/papers/v1/42525317/references?page=2